These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

465 related items for PubMed ID: 17427560

  • 1. [Short communication: comparison of susceptibilities of Escherichia coli urinary tract isolates against fosfomycin tromethamine and different antibiotics].
    Aykut Arca E, Karabiber N.
    Mikrobiyol Bul; 2007 Jan; 41(1):115-9. PubMed ID: 17427560
    [Abstract] [Full Text] [Related]

  • 2. Antimicrobial susceptibilities of urinary extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae to fosfomycin and nitrofurantoin in a teaching hospital in Taiwan.
    Liu HY, Lin HC, Lin YC, Yu SH, Wu WH, Lee YJ.
    J Microbiol Immunol Infect; 2011 Oct; 44(5):364-8. PubMed ID: 21524974
    [Abstract] [Full Text] [Related]

  • 3. Fosfomycin tromethamine as second agent for the treatment of acute, uncomplicated urinary tract infections in adult female patients in The Netherlands?
    Knottnerus BJ, Nys S, Ter Riet G, Donker G, Geerlings SE, Stobberingh E.
    J Antimicrob Chemother; 2008 Aug; 62(2):356-9. PubMed ID: 18424789
    [Abstract] [Full Text] [Related]

  • 4. [Antibiotic resistance rates of extended spectrum beta-lactamase producing Escherichia coli and Klebsiella spp. strains isolated from urinary tract infections in a private hospital].
    Akyar I.
    Mikrobiyol Bul; 2008 Oct; 42(4):713-5. PubMed ID: 19149097
    [Abstract] [Full Text] [Related]

  • 5. [In vitro activity of fosfomycin trometamol in the treatment of Escherichia coli related uncomplicated urinary tract infections].
    Hoşbul T, Ozyurt M, Baylan O, Bektöre B, Ardiç N, Ceylan S, Erdemoğlu A, Haznedaroğlu T.
    Mikrobiyol Bul; 2009 Oct; 43(4):645-9. PubMed ID: 20084918
    [Abstract] [Full Text] [Related]

  • 6. In vitro susceptibility of Escherichia coli strains isolated from urine samples obtained in mainland China to fosfomycin trometamol and other antibiotics: a 9-year surveillance study (2004-2012).
    Lai B, Zheng B, Li Y, Zhu S, Tong Z.
    BMC Infect Dis; 2014 Feb 06; 14():66. PubMed ID: 24502648
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of the in vitro activity of fosfomycin tromethamine against Gram-negative bacterial strains recovered from community- and hospital-acquired urinary tract infections in Turkey.
    Demir T, Buyukguclu T.
    Int J Infect Dis; 2013 Nov 06; 17(11):e966-70. PubMed ID: 23742831
    [Abstract] [Full Text] [Related]

  • 8. In vitro activity of fosfomycin against ciprofloxacin-resistant or extended-spectrum beta-lactamase-producing Escherichia coli isolated from urine and blood.
    Ko KS, Suh JY, Peck KR, Lee MY, Oh WS, Kwon KT, Jung DS, Lee NY, Song JH.
    Diagn Microbiol Infect Dis; 2007 May 06; 58(1):111-5. PubMed ID: 17300900
    [Abstract] [Full Text] [Related]

  • 9. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey.
    Arslan H, Azap OK, Ergönül O, Timurkaynak F, Urinary Tract Infection Study Group.
    J Antimicrob Chemother; 2005 Nov 06; 56(5):914-8. PubMed ID: 16174685
    [Abstract] [Full Text] [Related]

  • 10. [Fosfomycin susceptibility of urinary Escherichia coli isolates producing extended-spectrum beta-lactamase according to CLSI and EUCAST recommendations].
    Cağan Aktaş S, Gençer S, Batırel A, Hacıseyitoğlu D, Ozer S.
    Mikrobiyol Bul; 2014 Oct 06; 48(4):545-55. PubMed ID: 25492650
    [Abstract] [Full Text] [Related]

  • 11. Prevalence and antimicrobial susceptibility of Escherichia coli in outpatient urinary isolates in Izmir, Turkey.
    Yilmaz N, Agus N, Yurtsever SG, Pullukcu H, Gulay Z, Coskuner A, Kose S, Aydemir S, Gulenc N, Ozgenc O.
    Med Sci Monit; 2009 Nov 06; 15(11):PI61-5. PubMed ID: 19865064
    [Abstract] [Full Text] [Related]

  • 12. Antimicrobial susceptibility of clinical Escherichia coli isolates from uncomplicated cystitis in women over a 1-year period in Spain.
    Gobernado M, Valdés L, Alós JI, García-Rey C, Dal-Ré R, García-de-Lomas J, Spanish Surveillance Group for Urinary Pathogens.
    Rev Esp Quimioter; 2007 Mar 06; 20(1):68-76. PubMed ID: 17530038
    [Abstract] [Full Text] [Related]

  • 13. [The comparison of antibiotic susceptibilities of uropathogenic Escherichia coli isolates in transition from CLSI to EUCAST].
    Süzük S, Kaşkatepe B, Avcıküçük H, Aksaray S, Başustaoğlu A.
    Mikrobiyol Bul; 2015 Oct 06; 49(4):494-501. PubMed ID: 26649407
    [Abstract] [Full Text] [Related]

  • 14. [Characterization of class 1 and class 2 integron gene cassettes in Escherichia coli strains isolated from urine cultures: a multicenter study].
    Çopur Çiçek A, Sandallı C, Budak EE, Yağmur G, Çizmeci Z, Ak S, Balcı PÖ, Şay Coşkun SU, Ay Altıntop Y, Fırat M, Sarı F, Çalışkan A, Yıldız N, Sancaktar M, Özgümüş OB.
    Mikrobiyol Bul; 2016 Apr 06; 50(2):175-85. PubMed ID: 27175490
    [Abstract] [Full Text] [Related]

  • 15. In vitro susceptibility pattern of cephalosporin-resistant Gram-negative bacteria.
    Punpanich W, Tantichattanon W, Wongwatcharapaiboon S, Treeratweeraphong V.
    J Med Assoc Thai; 2008 Oct 06; 91 Suppl 3():S21-7. PubMed ID: 19255989
    [Abstract] [Full Text] [Related]

  • 16. [Resistance of Escherichia coli isolated from the urinary tract to amoxicillin-clavulanic acid and other antibiotics].
    Ferjani A, Marzouk M, Ben Moussa F, Boukadida J.
    Med Mal Infect; 2010 Mar 06; 40(3):161-4. PubMed ID: 19616395
    [Abstract] [Full Text] [Related]

  • 17. Antimicrobial resistance in outpatient Escherichia coli urinary isolates in Dakar, Senegal.
    Sire JM, Nabeth P, Perrier-Gros-Claude JD, Bahsoun I, Siby T, Macondo EA, Gaye-Diallo A, Guyomard S, Seck A, Breurec S, Garin B.
    J Infect Dev Ctries; 2007 Dec 01; 1(3):263-8. PubMed ID: 19734603
    [Abstract] [Full Text] [Related]

  • 18. Susceptibility of Escherichia coli strains isolated from outpatient children with community-acquired urinary tract infection in southern Switzerland.
    Borsari AG, Bucher B, Brazzola P, Simonetti GD, Dolina M, Bianchetti MG.
    Clin Ther; 2008 Nov 01; 30(11):2090-5. PubMed ID: 19108796
    [Abstract] [Full Text] [Related]

  • 19. Antimicrobial susceptibility of Escherichia coli from community-acquired urinary tract infections in Europe: the ECO·SENS study revisited.
    Kahlmeter G, Poulsen HO.
    Int J Antimicrob Agents; 2012 Jan 01; 39(1):45-51. PubMed ID: 22055529
    [Abstract] [Full Text] [Related]

  • 20. The antimicrobial activity of mecillinam, nitrofurantoin, temocillin and fosfomycin and comparative analysis of resistance patterns in a nationwide collection of ESBL-producing Escherichia coli in Norway 2010-2011.
    Zykov IN, Sundsfjord A, Småbrekke L, Samuelsen Ø.
    Infect Dis (Lond); 2016 Feb 01; 48(2):99-107. PubMed ID: 26414659
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.